Close
Smartlab Europe
Achema middle east

News

Moderna Confirms Discussions with U.S. Government for Additional 100 Million Doses of the Moderna COVID-19 Vaccine

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines confirmed that the Company is in discussion with the U.S. government to purchase an additional 100 million doses of the Moderna COVID-19 Vaccine for delivery in the...

Dr Reddys Labs, GRA terminate Avigan study for Covid-19 treatment in Kuwait

Dr Reddy's Laboratories Ltd. and Global Response Aid FZCO (GRA) announced the termination of Avigan trial conducted in Kuwait focused on moderate to severe Covid patients in a hospital setting. The hospitalized patient study, conducted in Kuwait, on moderate to...

CEVA Logistics signs a MOU with the Hope Consortium to provide logistics support for COVID-19 vaccine distribution worldwide

CEVA Logistics has signed a Memorandum of Understanding with Abu Dhabi Ports to work with the Hope Consortium. The Consortium is the umbrella organization of a UAE-based public-private partnership set up to address the logistical challenge of the worldwide...

Covaxin effectively neutralises UK variants: Bharat Biotech

Vaccine maker Bharat Biotech said that its coronavirus vaccine Covaxin has been found effective against the UK variant of the virus, which is considered 70 per cent more infectious than the Wuhan variety and is more lethal. In a...

GSK, PATH, and Bharat Biotech sign product transfer agreement to help ensure long-term supply of RTS,S/AS01E malaria vaccine

GSK, PATH, and Bharat Biotech announced the signing of a product transfer agreement for the malaria vaccine, RTS,S/AS01E1. The agreement includes the transfer of manufacturing of the RTS,S antigen part of the vaccine and the grant of a license...

X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend and Streamline Drug Discovery Service Range

X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its US-based sister company, AviSyn. The transaction will enable the Company to offer a complete, seamless solution...

Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation

Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located in the Incheon Free Economic Zone (IFEZ), a specially-designated economic zone in the city of Incheon. The new site is approximately...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »